Bavarian Nordic said on Thursday it has signed an agreement with the United Nations Children's Fund (UNICEF) for one million ...

Bavarian Nordic has received an order worth $63 million from the U.S. government to produce additional bulk product and the ...

The vaccine bulk manufacturing is scheduled for 2025 with the delivery of the freeze-dried doses set for 2026.

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September ...

Research shows that the effectiveness of Bavarian Nordic’s Mpox vaccine drops to undetectable levels after 6-12 months.

Bavarian Nordic A/S, one of a few companies with an approved mpox vaccine, is upgrading its financial guidance after securing more orders for its jab as an outbreak rages in Africa.

Bavarian Nordic has received a $63 million order from BARDA to produce Jynneos mpox vaccine doses. The contract will support ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

Bavarian Nordic has secured a $63 million contract from the U.S. government to produce the Jynneos vaccine for mpox and ...

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with ...

(RTTNews) - Bavarian Nordic A/S (BVNRY.PK), Thursday announced an updated guidance for the fiscal year 2024, primarily due to the bulk Mpox vaccine orders secured by the company as well as improved ...

Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...